Korean researchers at KAIST and the Institute for Basic Science have uncovered a previously unknown mechanism by which VEGF-C — a key protein in lymphatic vessel development — amplifies its own signaling. Using cryogenic electron microscopy (cryo-EM), the team mapped the 3D structure of the VEGF-C–VEGFR-3 complex and found that after VEGF-C brings two VEGFR-3 receptors together, multiple such pairs further cluster along the cell membrane, dramatically boosting the signal. Think of it like teams of two joining forces to form a much larger, more powerful group.

This "hidden amplification switch" could be significant for two very different diseases. In lymphedema, where lymphatic vessels are underdeveloped or damaged, boosting this signaling could help restore drainage. In cancer, where excess lymphatic vessels around tumors help cancer cells spread, suppressing this clustering could potentially slow metastasis.

Key Takeaways:

• VEGF-C drives lymphatic vessel growth by clustering VEGFR-3 receptor pairs into higher-order complexes along the cell membrane
• Disrupting or enhancing this clustering could offer a new therapeutic target for lymphedema or cancer metastasis
• No therapeutic effects have been demonstrated yet — further research is needed before clinical application

Why it matters: Lymphedema affects millions worldwide with limited treatment options, and lymphatic involvement in cancer spread remains a major clinical challenge. This structural discovery opens a new regulatory target that could eventually lead to precision therapies for both conditions.